The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice.
about
Fas-ligand: privilege and perilDeath receptor-ligand systems in cancer, cell death, and inflammationAdvances in haplo-identical stem cell transplantation in adults with high-risk hematological malignanciesGranzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity.The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.Fas and Fas ligand in gut and liver.Alterations in molecular killing mechanisms: implications in skin disease.Cytolytic pathways in haematopoietic stem-cell transplantation.An epidermotypic model of interface dermatitis reveals individual functions of fas ligand and gamma interferon in hypergranulosis, cytoid body formation, and gene expression.Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants.Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes.An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse.Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment.CCR2 is required for CD8-induced graft-versus-host disease.Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin functionPathophysiology of acute graft-versus-host disease: recent advances.The effect of graft-versus-host disease on T cell production and homeostasis.Keratinocyte apoptosis in epidermal development and disease.Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathologyA novel role for the semaphorin Sema4D in the induction of allo-responsesParaneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis.Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.Proinflammatory consequences of transgenic fas ligand expression in the heart.Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies.Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantationFas ligand- mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host diseaseInterleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease.Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.Acute graft-versus-host disease: from the bench to the bedside.IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation.Mouse models of graft-versus-host disease: advances and limitations
P2860
Q24612227-FD4D201C-579B-49DD-B683-3009E6CAFA2AQ26865568-C6F3C8E8-62DB-4908-8CBA-9E3EA1138A55Q27014857-ADA9366E-F30B-459C-A755-9946E7461289Q31909336-873D3DF0-EBFC-40E7-B76D-2BE31CCEADE3Q33724352-8EA2F07E-7105-436E-B614-4F9F0B41B8BEQ33857573-5BC83D3E-B842-4B78-B27A-5869F55EB472Q33860215-27EEDC46-D62B-448B-963D-0A8E6938B5B7Q34567275-0D51918D-89CC-4069-A50B-5D413360D20EQ34632083-22D941E8-9F85-40CA-A58F-70A70DC9075EQ34843615-4505C349-44C9-41AE-8F25-2D051F873299Q35158939-E0273894-3226-43FD-91D0-99E0A4CD673EQ35209364-5C5CF043-3910-4734-A45A-72E70710EA5DQ35522357-1C10E600-AA52-44E4-B25F-D12671D2BBF8Q35525740-303E3772-F9FC-4542-A933-CB02F4DF75FCQ35669245-C8BE6521-38AE-4224-91A6-26F28D71AEF9Q35694784-60DE17F7-39C9-48B5-A157-32C8C088E40CQ35750939-C5471C52-5929-4EC7-9478-4BBFFC118D83Q35839841-51AC2749-C1C2-4901-8067-37F22E0CC942Q35848441-C0F6A8D1-8B27-4B88-B00E-4ABE04D5BC20Q35858408-78B7E3BA-E4FD-4EE6-9A2B-914AD9403AB4Q35996711-20A36071-F985-4DD1-A21B-AF0D9BD998DEQ36156559-1446B584-2028-41B0-BFBF-44A02ACD6B0EQ36368034-1BFAB086-BA5F-409F-AE34-AFAECFC706A0Q36371190-C5C9DDF0-4B05-438E-9B99-63FCF813C24DQ36400410-6800D9DA-CA30-4DF6-BC49-B878EABAD912Q36515586-5BAE4D1B-CAFF-435E-BB5A-E6E0D166432EQ36652524-41E6FDAC-69EE-43B5-8C62-90D3D8CB03B0Q36765387-C52BB5F2-03B8-4DCD-9B40-C124ADC0D1E1Q37119943-F231234C-9B20-4747-9422-E752F5B87991Q37194997-2ACEA3B4-6FBC-4F7A-AF18-55F6CF430D08Q37223312-CD10FC35-CCE1-447E-9BCD-AFCC59C3068CQ37371294-F36C5912-59E3-40F7-9F55-E08FA608A470Q37377818-08EDDE42-6EEA-4489-BD9F-F54CE905CFD8Q37387081-AA19652A-FDB0-4390-9F75-F5F6D45DB2DDQ37388077-CA167CE2-1DF7-44C6-B092-3FA43E772B34Q37398338-D42308D8-ABC0-4A3A-AEF5-9D59B69D634DQ37416883-14E63413-CDE2-41F2-8FFA-5393C08F5428Q37420496-3C059DD2-4EEE-4C5F-8AD1-AEC0BB51A625Q37484523-3684ABB6-D45E-42BE-B8F4-12E4F8F737A4Q37874011-ECCC784D-86EE-48D3-8BB3-C52A3801D706
P2860
The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The role of cell-mediated cyto ...... arrow transplantation in mice.
@ast
The role of cell-mediated cyto ...... arrow transplantation in mice.
@en
type
label
The role of cell-mediated cyto ...... arrow transplantation in mice.
@ast
The role of cell-mediated cyto ...... arrow transplantation in mice.
@en
prefLabel
The role of cell-mediated cyto ...... arrow transplantation in mice.
@ast
The role of cell-mediated cyto ...... arrow transplantation in mice.
@en
P2093
P2860
P356
P1476
The role of cell-mediated cyto ...... arrow transplantation in mice.
@en
P2093
P2860
P304
P356
10.1084/JEM.183.6.2645
P407
P577
1996-06-01T00:00:00Z